Dynavax to Webcast Annual Meeting
BERKELEY, Calif., June 7 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative products to treat and prevent allergies, infectious diseases and chronic inflammatory diseases, will hold its annual shareholders meeting at the Company's principal executive offices at 2929 Seventh Street in Berkeley, California on Tuesday, June 15, 2004, at 10:00 a.m. Pacific Daylight Time.
Those unable to attend the meeting in person may listen to the webcast live at http://www.dynavax.com . A replay will be available on Dynavax's website for two weeks thereafter.
About Dynavax
Dynavax Technologies Corporation discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Our clinical development programs are based on immunostimulatory sequences, or ISS, which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
SOURCE Dynavax Technologies Corporation
-0- 06/07/2004
/CONTACT: Dino Dina, M.D., President and Chief Executive Officer of
Dynavax Technologies Corporation, +1-510-848-5100/
/Web site: http://www.dynavax.com /
(DVAX)
CO: Dynavax Technologies Corporation
ST: California
IN: MTC HEA BIO
SU: CCA
UC-JO
-- SFM108 --
5179 06/07/2004 11:25 EDT http://www.prnewswire.com